Global Patent Index - EP 1796610 A4

EP 1796610 A4 20121205 - TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE

Title (en)

TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE

Title (de)

TRANSDERMALES THERAPEUTISCHES SYSTEM FÜR PARKINSON-KRANKHEIT

Title (fr)

SYSTEME THERAPEUTIQUE TRANSDERMIQUE POUR LA MALADIE DE PARKINSON

Publication

EP 1796610 A4 20121205 (EN)

Application

EP 05802679 A 20050929

Priority

  • US 2005035257 W 20050929
  • US 61376004 P 20040929
  • US 61376104 P 20040929

Abstract (en)

[origin: WO2006039532A2] The invention provides a transdermal therapeutic system (TTS) containing rotigotine as the active ingredient. The TTS is useful in the treatment of Parkinson's Disease because it induces a pharmacokinetic profile where the rotigotine plasma level is high and stable.

IPC 8 full level

A61F 13/02 (2006.01); A61F 13/00 (2006.01); A61K 9/70 (2006.01); A61K 31/381 (2006.01)

CPC (source: EP)

A61K 9/7069 (2013.01); A61K 31/381 (2013.01)

Citation (search report)

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

Designated extension state (EPC)

HR MK

DOCDB simple family (publication)

WO 2006039532 A2 20060413; WO 2006039532 A3 20060713; EP 1796610 A2 20070620; EP 1796610 A4 20121205; JP 2008514376 A 20080508

DOCDB simple family (application)

US 2005035257 W 20050929; EP 05802679 A 20050929; JP 2007534813 A 20050929